Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer

Estrogen-receptor-negative breast cancer (BCER−) is mainly treated with chemotherapeutics. Leptin signaling can influence BCER− progression, but its effects on patient survival and chemoresistance are not well understood. We hypothesize that leptin signaling decreases the survival of BCER− patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipsey, Crystal C., Harbuzariu, Adriana, Robey, Robert W., Huff, Lyn M., Gottesman, Michael M., Gonzalez-Perez, Ruben R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311967/
https://www.ncbi.nlm.nih.gov/pubmed/32471192
http://dx.doi.org/10.3390/ijms21113794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311967/
https://www.ncbi.nlm.nih.gov/pubmed/32471192
http://dx.doi.org/10.3390/ijms21113794

Ejemplares similares